106 companies

Biotage

Market Cap: SEK 7.2b

Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

BIOT

SEK 90.55

7D

3.7%

1Y

-44.6%

BioGaia

Market Cap: SEK 10.2b

A healthcare company, provides probiotic products worldwide.

BIOG B

SEK 100.70

7D

2.2%

1Y

-15.0%

Camurus

Market Cap: SEK 33.2b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.

CAMX

SEK 566.00

7D

4.3%

1Y

19.5%

Bonesupport Holding

Market Cap: SEK 20.4b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

BONEX

SEK 309.40

7D

3.6%

1Y

30.2%

Newbury Pharmaceuticals

Market Cap: SEK 82.5m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

NEWBRY

SEK 3.40

7D

1.2%

1Y

-2.9%

Saniona

Market Cap: SEK 871.0m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, Germany, Denmark, the United Kingdom, and Mexico.

SANION

SEK 6.40

7D

-5.3%

1Y

239.3%

Swedish Orphan Biovitrum

Market Cap: SEK 90.3b

An integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

SOBI

SEK 263.00

7D

4.9%

1Y

1.4%

Ascelia Pharma

Market Cap: SEK 297.0m

A biotech company, focuses on orphan oncology treatments in Sweden.

ACE

SEK 3.09

7D

14.7%

1Y

-77.7%

Elicera Therapeutics

Market Cap: SEK 158.7m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

ELIC

SEK 3.27

7D

10.7%

1Y

178.3%

Corline Biomedical

Market Cap: SEK 219.9m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

CLBIO

SEK 8.98

7D

3.7%

1Y

-17.6%

NextCell Pharma

Market Cap: SEK 70.5m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.

NXTCL

SEK 0.96

7D

-18.3%

1Y

-63.3%

Devyser Diagnostics

Market Cap: SEK 1.5b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

DVYSR

SEK 89.90

7D

1.6%

1Y

-14.4%

Biovica International

Market Cap: SEK 78.4m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.

BIOVIC B

SEK 0.80

7D

0.3%

1Y

-65.1%

AcouSort

Market Cap: SEK 55.0m

A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies.

ACOU

SEK 3.68

7D

-1.1%

1Y

-63.2%

Lipigon Pharmaceuticals

Market Cap: SEK 17.8m

Develops drugs for lipid related diseases in Sweden.

LPGO

SEK 0.12

7D

1.3%

1Y

-58.6%

Modus Therapeutics Holding

Market Cap: SEK 46.0m

A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.

MODTX

SEK 1.28

7D

2.8%

1Y

24.9%

Genovis AB (publ.)

Market Cap: SEK 1.3b

Develops and sells tools for the development of new treatment methods and diagnostics for customers in the pharmaceutical and research industries.

GENO

SEK 19.92

7D

8.7%

1Y

-30.3%

Xbrane Biopharma

Market Cap: SEK 298.2m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

XBRANE

SEK 0.19

7D

6.7%

1Y

-46.5%

Vitrolife

Market Cap: SEK 20.9b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

VITR

SEK 154.60

7D

2.0%

1Y

-8.0%

Moberg Pharma

Market Cap: SEK 359.5m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

MOB

SEK 7.70

7D

6.9%

1Y

-71.6%

AlzeCure Pharma

Market Cap: SEK 218.1m

A pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

ALZCUR

SEK 2.47

7D

-0.8%

1Y

23.5%

Active Biotech

Market Cap: SEK 120.6m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

ACTI

SEK 0.098

7D

40.0%

1Y

-82.2%

BioArctic

Market Cap: SEK 14.9b

Develops biological drugs for patients with disorders of the central nervous system in Sweden.

BIOA B

SEK 168.10

7D

3.8%

1Y

-13.3%

Oncopeptides

Market Cap: SEK 447.5m

A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.

ONCO

SEK 1.98

7D

-0.6%

1Y

-56.3%

Swedencare

Market Cap: SEK 5.7b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

SECARE

SEK 35.60

7D

0.3%

1Y

-40.4%

Cinclus Pharma Holding

Market Cap: SEK 473.8m

A clinical stage pharmaceutical company, engages in the development of the drug candidate for the treatment of related diseases.

CINPHA

SEK 10.18

7D

-8.9%

1Y

n/a

Magle Chemoswed Holding

Market Cap: SEK 586.8m

Operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden.

MAGLE

SEK 28.60

7D

7.5%

1Y

-5.3%

SenzaGen

Market Cap: SEK 145.2m

Provides non-animal tests for assessing a substance’s allergenicity.

SENZA

SEK 4.92

7D

15.8%

1Y

-24.3%

MedCap

Market Cap: SEK 5.8b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.

MCAP

SEK 385.50

7D

7.7%

1Y

-4.1%

Annexin Pharmaceuticals

Market Cap: SEK 143.9m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.

ANNX

SEK 0.27

7D

-6.9%

1Y

-1.1%

Xspray Pharma

Market Cap: SEK 1.3b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

XSPRAY

SEK 35.60

7D

17.5%

1Y

-10.3%

Scandion Oncology

Market Cap: SEK 2.8m

A clinical-stage biotechnology company, develops medicines for the treatment of cancer.

SCOL

SEK 0.012

7D

-4.8%

1Y

-99.5%

Alzinova

Market Cap: SEK 172.3m

A biopharmaceutical company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

ALZ

SEK 1.93

7D

3.8%

1Y

10.4%

Biosergen

Market Cap: SEK 68.8m

A biotech company, develops antifungal products.

BIOSGN

SEK 0.29

7D

-2.3%

1Y

-39.1%

BICO Group

Market Cap: SEK 2.5b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

BICO

SEK 35.86

7D

5.8%

1Y

-20.3%

AddLife

Market Cap: SEK 18.8b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

ALIF B

SEK 154.00

7D

7.1%

1Y

57.5%

Page 1 of 3